- Home
- NBIX vs RVTY Comparison
NBIX vs RVTY Comparison
Compare NBIX & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- RVTY
- Stock Information
- Founded
- NBIX 1992
- RVTY 1937
- Country
- NBIX United States
- RVTY United States
- Employees
- NBIX N/A
- RVTY N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- NBIX Health Care
- RVTY Industrials
- Exchange
- NBIX Nasdaq
- RVTY Nasdaq
- Market Cap
- NBIX 12.2B
- RVTY 11.1B
- IPO Year
- NBIX 1996
- RVTY N/A
- Fundamental
- Price
- NBIX $128.00
- RVTY $99.00
- Analyst Decision
- NBIX Strong Buy
- RVTY Buy
- Analyst Count
- NBIX 20
- RVTY 13
- Target Price
- NBIX $163.20
- RVTY $123.92
- AVG Volume (30 Days)
- NBIX 879.2K
- RVTY 1.1M
- Earning Date
- NBIX 07-31-2025
- RVTY 07-28-2025
- Dividend Yield
- NBIX N/A
- RVTY 0.28%
- EPS Growth
- NBIX N/A
- RVTY 95.55
- EPS
- NBIX 2.96
- RVTY 2.35
- Revenue
- NBIX $2,412,600,000.00
- RVTY $2,769,868,000.00
- Revenue This Year
- NBIX $16.29
- RVTY $5.55
- Revenue Next Year
- NBIX $15.08
- RVTY $5.98
- P/E Ratio
- NBIX $42.50
- RVTY $42.20
- Revenue Growth
- NBIX 21.73
- RVTY 1.62
- 52 Week Low
- NBIX $84.23
- RVTY $87.70
- 52 Week High
- NBIX $157.98
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- NBIX 62.53
- RVTY 59.97
- Support Level
- NBIX $125.02
- RVTY $95.97
- Resistance Level
- NBIX $128.66
- RVTY $101.28
- Average True Range (ATR)
- NBIX 2.68
- RVTY 2.72
- MACD
- NBIX -0.34
- RVTY 0.45
- Stochastic Oscillator
- NBIX 80.79
- RVTY 66.17
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.